Visa (V) Shares Approaching All-Time High, Up 3+% Today
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall Street ends lower, off record highs, as Treasury yields climb
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Chip stock could soar nearly 200%, analyst says: "If you don’t buy it, they will"
- Musk rules out TSMC role in Terafab operations; Intel gains
Tweet
Share
E-mailGet Alerts V Hot Sheet
Price: $372.10 +0.39%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
Revenue Growth %: +12.9%
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 0.9%
Revenue Growth %: +12.9%
Join SI Premium – FREE
Shares of Visa (NYSE: V) are hovering close to an all-time high of $97.19 Wednesday. The stock is up more than 3.2 percent to $95.88 at last check.
While the company has recently been quiet on the news front, a new almost 2.3 million share stake by Warren Buffett's Berkshire Hathaway disclosed in mid-November may have given investors that extra bit of confidence.
Analysts are also behind the stock: out of 34 analyst firms covering the stock, 14 are currently at Strong Buy and 13 are at Buy.
Notably, close peer MasterCard (NYSE: MA) recently marked a fresh all-time high at $373.55 on November 15th.
While the company has recently been quiet on the news front, a new almost 2.3 million share stake by Warren Buffett's Berkshire Hathaway disclosed in mid-November may have given investors that extra bit of confidence.
Analysts are also behind the stock: out of 34 analyst firms covering the stock, 14 are currently at Strong Buy and 13 are at Buy.
Notably, close peer MasterCard (NYSE: MA) recently marked a fresh all-time high at $373.55 on November 15th.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) vs. Mastercard (MA): Which payments stock to own into Q3 earnings
- Fresenius Medical Care (FMS) halted, news pending
- Xenon Pharmaceuticals (XENE) Jumps 6% Following a 35% Down Month As Insiders Report Buys
Create E-mail Alert Related Categories
Insider Trades, Trader TalkRelated Entities
Warren BuffettSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
